Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging - Tabular View

Tracking Information

First Received Date ^ICMJE

January 3, 2008

Last Updated Date

January 3, 2008

Start Date ^ICMJE

May 1999

Estimated Primary Completion Date

January 2010 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Improve image quality by various techniques (e.g. reducing the effects of motion) [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Descriptive Information

Brief Title ^ICMJE

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

Official Title ^ICMJE

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

Brief Summary

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.

Detailed Description

This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Case Control, Prospective

Condition ^ICMJE

Abnormalities, Cardiovascular

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Active, not recruiting

Estimated Enrollment ^ICMJE

120

Estimated Completion Date

January 2010

Estimated Primary Completion Date

January 2010 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

18 years of age or older
Ability to give informed, written consent
Not Pregnant or breastfeeding

Exclusion Criteria:

Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)
Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis
History of uncontrolled claustrophobia

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Administrative Information

NCT ID ^ICMJE

NCT00593541

Responsible Party

Michael Buonocore, MD, PhD, UC Davis Medical Center

Study ID Numbers ^ICMJE

200210689

Study Sponsor ^ICMJE

University of California, Davis

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Michael H Buonocore, MD, PhD

University of California, Davis

Information Provided By

University of California, Davis

Verification Date

January 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP